Cardiac Tissue Engineering for the Treatment of Myocardial Infarction
Poor cell engraftment rate is one of the primary factors limiting the effectiveness of cell transfer therapy for cardiac repair. Recent studies have shown that the combination of cell-based therapy and tissue engineering technology can improve stem cell engraftment and promote the therapeutic effect...
Збережено в:
| Автори: | , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
MDPI AG
2021-11-01
|
| Серія: | Journal of Cardiovascular Development and Disease |
| Предмети: | |
| Онлайн доступ: | https://www.mdpi.com/2308-3425/8/11/153 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|